Novo Nordisk, FDA

Under US law, compounding pharmacies can make and sell patent-protected drugs that are on the FDA's shortages list in limited ...
The Danish drugmaker asked the agency to put semaglutide, the active ingredient in Wegovy and Ozempic, on a list of drugs ...
The war is on between compounding pharmacies making knockoff versions of popular weight loss drugs and pharma giants Novo ...
Novo Nordisk has nominated semaglutide for inclusion in the FDA’s Demonstrable Difficulties for Compounding list, which ...
Novo Nordisk is continuing its crusade against compounded versions of its blockbuster weight loss drugs by petitioning the ...